Drugrehab: What It Is and Why It Matters

The directory assembled at this domain indexes reference-grade information about medical and health services within the substance use disorder treatment continuum across the United States. Each section documents the structure, regulatory framework, and classification logic that governs how treatment services are organized, licensed, and delivered. The scope spans inpatient and outpatient settings, pharmacological interventions, behavioral health services, and the credentialing standards applied to facilities and clinicians. Understanding the directory's purpose and maintenance logic allows readers to evaluate listings accurately and locate the correct category of information for a given research need.

How the directory is maintained

Directory content is organized according to classification frameworks established by recognized federal and accreditation bodies. The primary structural reference is the American Society of Addiction Medicine (ASAM) Criteria, a level-of-care framework that stratifies treatment services from early intervention through medically managed intensive inpatient care. Listings referencing level of care align to the ASAM continuum — Level 0.5 through Level 4 — to ensure that categorical labels carry consistent clinical meaning across entries.

Regulatory alignment draws from the Substance Abuse and Mental Health Services Administration (SAMHSA), which administers the federal block grant system under 42 U.S.C. § 300x and publishes the National Survey on Drug Use and Health (NSDUH). Facility certification standards referenced in the directory correspond to SAMHSA's certification requirements for opioid treatment programs (OTPs) as codified in 42 CFR Part 8. Accreditation status markers reflect the standards of The Joint Commission (TJC) and the Commission on Accreditation of Rehabilitation Facilities (CARF), both of which publish detailed behavioral health standards manuals — a comparison of these two bodies is covered at Rehab Accreditation and Licensing.

Content is reviewed for alignment with Drug Enforcement Administration (DEA) scheduling classifications under 21 U.S.C. § 812 when listings involve controlled substances used in treatment, such as buprenorphine (Schedule III) or methadone (Schedule II). Privacy-related framing within listings acknowledges the federal confidentiality protections applicable to substance use disorder records under 42 CFR Part 2, which imposes stricter disclosure limits than the HIPAA Privacy Rule at 45 CFR § 164.

No individual facility performance data, patient outcome rates, or real-time availability figures are included, as those data points require dynamic sourcing beyond the scope of a static reference directory.

What the directory does not cover

The directory is a reference index, not a treatment locator, clinical intake tool, or insurance verification service. Listings do not include real-time bed availability, cost quotes, or payer-specific authorization status. Financial coverage mechanics — including Medicaid reimbursement structures and the mental health parity requirements established by the Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 — are addressed in the Drug Rehab Insurance Coverage reference section but are not reflected in individual facility listings.

The directory does not adjudicate quality disputes between providers, reproduce state inspection reports, or summarize enforcement actions. Readers researching regulatory violations should consult state behavioral health licensing boards directly; in the federal sphere, SAMHSA's Behavioral Health Treatment Services Locator and the Office of Inspector General (OIG) exclusion database are named primary sources for that type of inquiry.

Listings do not substitute for the formal Drug Rehab Admissions Process, which involves clinical screening, ASAM placement matching, insurance authorization, and informed consent — steps that require direct engagement with a licensed clinical team.

Services falling outside the substance use disorder treatment continuum — including primary care, emergency medicine, and general psychiatric hospitalization not tied to a co-occurring disorder diagnosis in the addiction context — are outside scope. For co-occurring mental health conditions documented alongside a substance use disorder diagnosis, the Co-Occurring Disorders and Dual Diagnosis reference page delineates how integrated treatment models are classified.

Relationship to other network resources

The directory functions as the categorical index layer for the full reference network on this domain. Topical explainer pages elaborate on individual service categories in depth; the directory provides the structural map between those categories.

Three tiers of content operate in parallel:

1. Classification and criteria pages — Document how services are defined, stratified, and regulated. Examples include Levels of Care: ASAM Criteria, Substance Use Disorder Diagnosis, and SAMHSA-Certified Treatment Programs.
2. Service-type reference pages — Describe discrete treatment modalities, including Medication-Assisted Treatment Overview, Detox Services in Drug Rehab, Partial Hospitalization Programs, and Intensive Outpatient Programs.
3. Population and context pages — Address clinically distinct subpopulations or setting variables, such as Adolescent Drug Rehab Programs, Veterans Drug Rehab Programs, and LGBTQ-Inclusive Rehab Programs.

The directory does not rank or sequence these resources by preference. Readers navigating the full reference architecture should begin with How to Use This Medical and Health Services Resource, which maps content by research intent rather than alphabetical or topical sequence.

How to interpret listings

Each listing entry identifies a service category by its regulatory or clinical classification label, not by proprietary program names. Classification labels follow the ASAM, SAMHSA, and DSM-5-TR (Diagnostic and Statistical Manual, Fifth Edition, Text Revision) nomenclature systems. Where terminology differs between these three frameworks — for example, ASAM's "Level 3.5 Clinically Managed High-Intensity Residential" versus a colloquial reference to "long-term residential" — both labels appear with a crosswalk notation.

Accreditation status markers, when present, distinguish between:

• Nationally accredited — Facility holds active TJC or CARF behavioral health accreditation, verifiable through each body's public online directory.
• State-licensed only — Facility holds a current state behavioral health or substance use disorder facility license without national accreditation.
• OTP-certified — Facility is federally certified under 42 CFR Part 8 to dispense opioid agonist medications, including methadone, for opioid use disorder treatment.

These three categories are mutually non-exclusive; a single facility may hold all three designations simultaneously. Accreditation does not imply clinical superiority, and the absence of national accreditation does not indicate regulatory noncompliance — state licensure alone satisfies the minimum legal operating threshold in most jurisdictions.

Listings referencing patient rights content align to protections codified under 42 CFR Part 2 and the Americans with Disabilities Act (ADA), the latter of which classifies substance use disorder in recovery as a protected disability condition under 42 U.S.C. § 12102. Detailed patient rights framing is covered separately at Patient Rights in Drug Rehab.